Sanuwave Health (SNWV) has released an update to notify the public and investors about an entry into a material definitive agreement.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Sanuwave Health, Inc. issued Asset-Backed Secured Promissory Notes totaling $4.6 million at a discount to accredited investors, with zero percent interest, maturing on January 21, 2023. Upon maturity, the company agreed to issue Future Advance Convertible Promissory Notes equivalent to the principal of the ABL Notes and two sets of Common Stock Purchase Warrants. A subsequent private placement on January 21, 2024, involved no cash proceeds but included the issuance of similar promissory notes and warrants, with the warrants having a five-year term and adjustable exercise prices. The company also entered into several agreements, including a security agreement, subordination agreement, and registration rights agreement, and received waivers from investors concerning certain obligations.
For further insights into SNWV stock, check out TipRanks’ Stock Analysis page.
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue